Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy

JAMA

Volumn 275, Issue 10, 1996, Pages 777-782

  Weaver, W Douglas ^a   White, Harvey D ^b   Wilcox, Robert G ^c   Aylward, Philip E ^d   Morris, Douglas ^e   Guerci, Alan ^f   Ohman, E Magnus ^g   Barbash, Gabriel I ^h   Betriu, Amadeo ⁱ   Sadowski, Zygmunt ^j   Topol, Eric J ^k   Califf, Robert M ^g  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b GREEN LANE HOSPITAL   (New Zealand)

^c QUEEN S MEDICAL CENTRE   (United Kingdom)

^d Flinders Cardiovascular Centre   (Australia)

^e EMORY CLINIC   (United States)

^f ST FRANCIS HOSPITAL   (United States)

^g DUKE UNIVERSITY MEDICAL CENTER   (United States)

^h TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

ⁱ HOSPITAL CLÍNIC   (Spain)

^j INSTITUTE OF CARDIOLOGY   (Poland)

^k LERNER RESEARCH INSTITUTE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT; HEPARIN; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLEEDING; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FIBRINOLYTIC THERAPY; HEART MUSCLE REVASCULARIZATION; HEART REINFARCTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; SHOCK; STROKE; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

EID: 9044241687     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.275.10.777     Document Type: Article

References (29)

1. Maynard C, Litwin PE, Martin JS, Weaver WD. Gender differences in the treatment and outcome of acute myocardial infarction: results from the Myocardial Infarction, Triage, and Intervention Registry. Arch Intern Med. 1992;152:972-976.
2. Maynard C, Litwin PE, Martin JS, Weaver DW. Treatment and outcome of acute myocardial infarction in women 75 years of age and older: findings from the Myocardial Infarction, Triage, and Intervention Registry. Cardiol Elderly. 1993;1:121-125.
3. Tofler GH, Stone PH, Muller JE, Braunwald E. Mortality for women after acute myocardial infarction: MILIS Study Group. Am J Cardiol. 1989;64: 256.
4. Tofler GH, Stone PH, Muller JE, et al, for the MILIS Study Group. Effects of gender and race on prognosis after myocardial infarction: adverse prognosis for women, particularly black women. J Am Coll Cardiol. 1987;9:473-482.
5. Behar S, Zahavi Z, Goldbourt U, Reicher-Reiss H. Long-term prognosis of patients with paroxysmal atrial fibrillation complicating acute myocardial infarction: SPRINT Study Group. Eur Heart J. 1992;13:45-50.
6. Gomez-Marin O, Folsom AR, Kottke TE, et al. Improvement in long-term survival among patients hospitalized with acute myocardial infarction: 1970 to 1980. N Engl J Med. 1937;316:1353-1359.
7. Dittrich H, Gilpin E, Nicod P, Cali G, Henning H, Ross J Jr. Acute myocardial infarction in women: influence of gender on mortality and prognostic variables. Am J Cardiol 1988;62:1-7.
8. Puletti M, Sunseri L, Curione M, Erba SM, Borgia C. Acute myocardial infarction: sex-related differences in prognosis. Am Heart J. 1984;108:63-66.
9. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomized trials of more than 1000 patients. Lancet. 1994;343:311-322.
10. White HD, Barbash GI, Modan M. After correcting for worse baseline characteristics, women treated with thrombolytic therapy for acute myocardial infarction have the same mortality and morbidity as men except for a higher incidence of hemorrhagic stroke: the investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Study. Circulation. 1993;88:2097-2103.
11. Fiebach NH, Viscoli CM, Horwitz RI. Differences between women and men in survival after myocardial infarction: biology or methodology? JAMA. 1990;263:1092-1096.
12. Greenland P, Reicher-Reiss H, Goldbourt U, Behar S, for the Israeli SPRINT Investigators. In-hospital and 1-year mortality in 1,524 women after myocardial infarction: comparison with 4,315 men. Circulation. 1991;83:484-491.
13. Lincoff AM, Califf RM, Ellis SG, et al, for the Thrombolysis and Angioplasty in Myocardial Infarction Study Group. Thrombolytic therapy for women with myocardial infarction: is there a gender gap? J Am Coll Cardiol. 1993;22:1780-1787.
14. Steingart RM, Packer M, Hamm P, et al, for the Survival and Ventricular Enlargement Investigators. Sex differences in the management of coronary artery disease. N Engl J Med. 1991:325:226-230.
15. Krumholz HM, Douglas PS, Lauer MS, Pasternak RC. Selection of patients for coronary angiography and coronary revascularization early after myocardial infarction: is there evidence for gender bias? Ann Intern Med. 1991;116:785-790.
16. Ayanian JZ, Epstein AM. Differences in the use of procedures between women and men hospitalized for coronary heart disease. N Engl J Med. 1991;325:221-225.
17. Mueller HS, Cohen LS, Braunwald E, et al, for the TIMI Investigators. Predictors of early morbidity and mortality after thrombolytic therapy of acute myocardial infarction: analyses of patient subgroups in the Thrombolysis in Myocardial Infarction (TIMI) trial, phase II. Circulation. 1992;85: 1254-1264.
18. The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med. 1993;329:673-682.
19. Lee KL, Woodlief LH, Topol EJ, et al, for the GUSTO-I Investigators. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction: results from an international trial of 41,021 patients. Circulation. 1995;91:1659-1668.
20. The GUSTO Angiographic Investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med. 1993;329:1615-1622.
21. Weaver WD, Litwin PE, Martin JS, et al. Effect of age on use of thrombolytic therapy and mortality in acute myocardial infarction: the MITI Project Group. J Am Coll Cardiol. 1991;18:657-662.
22. Weaver WD, for the National Registry of Myocardial Infarction Investigators. Factors influencing the time to hospital administration of thrombolytic therapy: results from a large national registry. Circulation. 1992;86:1-16. Abstract 0060.
23. Ridolfo B, Jamrozik KD, Hobbs M, Parsons RW, Broadhurst RJ, Thompson PL. Gender bias in management of myocardial infarction: prevalence and relevance to outcome. J Am Coll Cardiol. 1993; 21:238A. Abstract 906-27.
24. Maggioni AP, Franzosi MG, Santoro E, White H, Van de Werf F, Tognoni G, for the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico II (GISSI-2) and International Study Group. The risk of stroke in patients with acute myocardial infarction after thrombolytic and antithrombotic treatment. N Engl J Med. 1992; 327:1-6.
25. Mazeika PK, Nadazdin A, Oakley CM. Influence of haemodynamics and myocardial ischaemia on Doppler transmitral flow in patients undergoing dobutamine echocardiography. Eur Heart J. 1994; 15:17-25.
26. Vasan RS, Benjamin EJ, Levy D. Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective. J Am Coll Cardiol. 1995;26:1565-1574.
27. Higginbotham MB, Morris KG, Coleman RE, Cobb FR. Sex related differences in the normal cardiac response to upright exercise. Circulation. 1984;70:357-366.
28. Chiriboga DE, Yarzebski J, Goldberg RJ, et al. A community-wide perspective of gender differences and temporal trends in the use of diagnostic and revascularization procedures for acute myocardial infarction. Am J Cardiol. 1993;71:268-273.
29. Maynard C, Weaver WD. Treatment of women with acute MI: new findings from the MITI Registry. J Myocardial Ischemia. 1992;4:27-37.